ATE382056T1 - Virulenz gene, proteine, und ihre verwendung - Google Patents

Virulenz gene, proteine, und ihre verwendung

Info

Publication number
ATE382056T1
ATE382056T1 AT01925742T AT01925742T ATE382056T1 AT E382056 T1 ATE382056 T1 AT E382056T1 AT 01925742 T AT01925742 T AT 01925742T AT 01925742 T AT01925742 T AT 01925742T AT E382056 T1 ATE382056 T1 AT E382056T1
Authority
AT
Austria
Prior art keywords
genes
proteins
virulence genes
virulence
products
Prior art date
Application number
AT01925742T
Other languages
English (en)
Inventor
Christoph Tang
Original Assignee
Microscience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microscience Ltd filed Critical Microscience Ltd
Application granted granted Critical
Publication of ATE382056T1 publication Critical patent/ATE382056T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/36—Neisseria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT01925742T 2000-05-08 2001-05-08 Virulenz gene, proteine, und ihre verwendung ATE382056T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0011108.8A GB0011108D0 (en) 2000-05-08 2000-05-08 Virulence gene and protein and their use

Publications (1)

Publication Number Publication Date
ATE382056T1 true ATE382056T1 (de) 2008-01-15

Family

ID=9891203

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01925742T ATE382056T1 (de) 2000-05-08 2001-05-08 Virulenz gene, proteine, und ihre verwendung

Country Status (16)

Country Link
US (2) US20040087770A1 (de)
EP (2) EP1287024B1 (de)
JP (1) JP2003532404A (de)
KR (3) KR20030032948A (de)
CN (2) CN1840665A (de)
AT (1) ATE382056T1 (de)
AU (1) AU776508B2 (de)
CA (1) CA2408738A1 (de)
CZ (1) CZ20023642A3 (de)
DE (1) DE60132084T2 (de)
GB (1) GB0011108D0 (de)
HU (1) HUP0302481A2 (de)
NO (1) NO20025329L (de)
NZ (3) NZ522277A (de)
RU (2) RU2252224C2 (de)
WO (1) WO2001085772A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69526377T2 (de) 1994-12-09 2002-11-07 Microscience Ltd Virulenzgene in der VGC2-Region von Salmonella
WO2000014240A2 (en) 1998-09-04 2000-03-16 Creatogen Aktiengesellschaft Attenuated salmonella sp12 mutants as antigen carriers
US7666988B1 (en) 1999-03-12 2010-02-23 Glaxosmithkline Biologicals S.A. BASB082 Polypeptides
GB9910812D0 (en) 1999-05-10 1999-07-07 Microscience Ltd Vaccine composition
CA2493124C (en) * 2002-08-02 2014-04-29 Glaxosmithkline Biologicals S.A. Vaccine
GB0330007D0 (en) * 2003-12-23 2004-01-28 Imp College Innovations Ltd Vaccines
EP2425853A1 (de) 2005-04-08 2012-03-07 Wyeth LLC Multivalente Pneumokokken-Polysaccharidproteinkonjugatzusammensetzung
US7709001B2 (en) 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
EP2573080A1 (de) * 2007-09-27 2013-03-27 The United States of America, as Represented by the Secretary, Department of Health and Human Services Isoindolinverbindungen zur Behandlung von spinaler Muskelatrophie und für andere Anwendungen
US8703153B2 (en) 2008-06-16 2014-04-22 Prokarium Ltd. Salmonella vectored vaccines against Chlamydia and methods of use
GB0816447D0 (en) * 2008-09-08 2008-10-15 Glaxosmithkline Biolog Sa Vaccine
BR112012022800A2 (pt) * 2010-03-11 2018-05-15 Glaxosmithkline Biologicals Sa composição imunogênica ou vacina, cepa bacteriana gram-negativa geneticamente engenheirada, métodos para o tratamento ou prevenção de infecção ou doença, para produzir uma composição imunogênica ou uma vacina, e para preparar uma imunoglobulina, preparação da imunoglobulina, e, preparação farmacêutica
CN111118043B (zh) * 2020-01-13 2022-07-05 吉林大学 一种苦豆子SaMET6基因克隆及其应用
CN116042562B (zh) * 2022-03-11 2023-10-20 山东恒鲁生物科技有限公司 重组酵母菌及其应用
CN118388591B (zh) * 2023-11-24 2025-01-21 中国水产科学研究院黄海水产研究所 南极磷虾ace抑制肽apgr、fgaggl、lsgay及其应用
CN119080891B (zh) * 2024-11-11 2025-03-11 四川大学华西医院 鲍曼不动杆菌TonB重组蛋白抗原、制备方法及其应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE121947T1 (de) * 1989-12-14 1995-05-15 Ca Nat Research Council Verbessertes meningokokkale polysaccharidkonjugatvakzin.
CA2047043A1 (en) * 1990-07-19 1992-01-20 Allen I. Oliff Class ii protein of the outer membrane of neisseria meningitidis having immune enhancement properties
US5338664A (en) * 1992-12-04 1994-08-16 American Cyanamid Company Assay for detection of bacterial iron transport inhibitors
US6121037A (en) * 1994-10-18 2000-09-19 Stojiljkovic; Igor Bacterial hemoglobin receptor genes
DE69526377T2 (de) * 1994-12-09 2002-11-07 Microscience Ltd Virulenzgene in der VGC2-Region von Salmonella
FR2751000B1 (fr) * 1996-07-12 1998-10-30 Inst Nat Sante Rech Med Adn specifiques des bacteries de l'espece neisseria meningitidis, leurs procedes d'obtention et leurs applications biologiques
US6472518B1 (en) * 1996-10-24 2002-10-29 Centers For Disease Control And Prevention, As Represented By The Secretary, Department Of Health And Human Services Invasion associated genes from Neisseria meningitidis serogroup B
GB9711964D0 (en) * 1997-06-09 1997-08-06 Medical Res Council Live attenuated vaccines
BR9811907A (pt) * 1997-08-15 2000-08-15 Univ Utrecht Proteìna de ligação de lactoferrina de neisseria
EP1900818A3 (de) * 1997-11-06 2008-06-11 Novartis Vaccines and Diagnostics S.r.l. Neissersche Antigene
BR9910005A (pt) * 1998-04-29 2001-01-16 American Cyanamid Co Composição de vacina, processos para imunização contra neisseria gonorrhoeae e para preparar uma composição de vacina, sequência de dna isolada e purificada, plasmìdeo, célula hospedeira, processo para produção de uma proteìna pilina recombinante quimérica de neisseria gonorrhoeae e neisseria meningitidis, proteìna pilina recombinante quimérica isolada e purificada de neisseria gonorhoeae e neisseria meningitidis, e, processo para imunização contra neisseria muningitidis
GB9811260D0 (en) * 1998-05-26 1998-07-22 Smithkline Beecham Biolog Novel compounds
MXPA01003557A (es) * 1998-10-09 2004-04-05 Chiron Corp Secuencias genomicas de neisseria y metodos para su uso.
US6610836B1 (en) * 1999-01-29 2003-08-26 Genome Therapeutics Corporation Nucleic acid amino acid sequences relating to Klebsiella pneumoniae for diagnostics and therapeutics
CA2371032A1 (en) * 1999-04-30 2000-11-09 Chiron Corporation Neisseria genomic sequences and methods of their use

Also Published As

Publication number Publication date
WO2001085772A2 (en) 2001-11-15
AU776508B2 (en) 2004-09-09
CN1427892A (zh) 2003-07-02
CZ20023642A3 (cs) 2003-04-16
US20040087770A1 (en) 2004-05-06
RU2252224C2 (ru) 2005-05-20
US20080241151A1 (en) 2008-10-02
KR20080080069A (ko) 2008-09-02
NO20025329L (no) 2003-01-06
EP1908839A3 (de) 2008-07-16
CN1840665A (zh) 2006-10-04
RU2005101623A (ru) 2006-07-10
EP1287024B1 (de) 2007-12-26
CA2408738A1 (en) 2001-11-15
AU5242201A (en) 2001-11-20
EP1908839A2 (de) 2008-04-09
NZ549068A (en) 2008-03-28
EP1287024A2 (de) 2003-03-05
KR20070102447A (ko) 2007-10-18
NZ532297A (en) 2005-07-29
NO20025329D0 (no) 2002-11-06
DE60132084D1 (de) 2008-02-07
KR20030032948A (ko) 2003-04-26
DE60132084T2 (de) 2008-12-11
NZ522277A (en) 2004-05-28
HUP0302481A2 (hu) 2003-10-28
WO2001085772A3 (en) 2002-03-28
JP2003532404A (ja) 2003-11-05
GB0011108D0 (en) 2000-06-28

Similar Documents

Publication Publication Date Title
DE60132084D1 (de) Virulenz gene, proteine, und ihre verwendung
DE60126249D1 (de) Heterologe expression von neisseria proteine
ATE427114T1 (de) Verwendung von hepcidin zur herstellung eines arzneimittels zur behandlung von eisenhomíostase stírungen
CY1107950T1 (el) Νεϊσσεριακες συνθεσεις εμβολιου και μεθοδοι
DK1741784T3 (da) 85kDa-antigen fra neisseria
DE69926729D1 (de) Transgenes kaninchen, dass ein funktionelles menschliches lipoprotein(a) exprimiert
ATE384797T1 (de) Streptococcus pyogenes virulenz gene und proteine und ihre verwendungen
ATE353366T1 (de) Nukleinsäure und protein, genannt 158p1d7, für die behandlung und erkennung von blasenkrebs und anderen krebsarten
BR0206251A (pt) Métodos para avaliar e tratar leucemia
ATE364090T1 (de) Parapockenviren, die fremd-dna enthalten, ihre herstellung und ihre verwendung in impfstoffen
NO20004781D0 (no) Svekkede bakterier anvendelige i vaksiner
ATE383425T1 (de) Virulenzgene und deren proteine und verwendungen
DE60126765D1 (de) Virulenz gene, proteine, und ihre verwendung
ATE466086T1 (de) Expec-spezifische proteine, entsprechende gene und ihre verwendungen
WO2001032697A3 (en) Virulence genes and proteins from brucella melitensis, and their use
EP1472375A4 (de) In kanzerösen mammazellen differentiell exprimierte genprodukte und ihre verwendungsverfahren
DK1074266T3 (da) Levende svækkede bakterier til anvendelse i vaccine
DK1313850T3 (da) Nucleinsyre og tilsvarende protein med navnet 85PB3 anvendelige til behandling og påvisning af cancer
ATE466023T1 (de) Mannose-spezifische adhesinen und deren vervendung
NO20030821L (no) Gener og proteiner, og deres anvendelse
DE60125507D1 (de) Nukleinsäuren und Proteine des mph3 Gens aus Mycoplasma hypopneumoniae und deren Verwendung
WO2001057075A3 (en) Virulence genes, proteins, and their use
DE10393455D2 (de) DNA-Expressionskonstrukt zur multiplen Genexpression
EP1383536A4 (de) Verwendung von herpesviren, herpesvirus-proteinen und die proteine kodierenden nukleinsäuren zur hemmung der ccr5-hiv-1 infektion und replikation

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties